您的位置: 专家智库 > >

国家自然科学基金(81273907)

作品数:9 被引量:63H指数:5
相关作者:杨艳萍沈霖徐晓娟帅波李成刚更多>>
相关机构:华中科技大学更多>>
发文基金:国家自然科学基金更多>>
相关领域:医药卫生更多>>

文献类型

  • 9篇中文期刊文章

领域

  • 9篇医药卫生

主题

  • 5篇青娥丸
  • 5篇坏死
  • 5篇骨头
  • 5篇股骨
  • 5篇股骨头
  • 4篇头坏死
  • 4篇骨头坏死
  • 4篇股骨头坏死
  • 3篇血性
  • 3篇缺血性坏死
  • 3篇活血
  • 3篇股骨头缺血
  • 3篇股骨头缺血性
  • 3篇股骨头缺血性...
  • 3篇非创伤性
  • 3篇补肾
  • 3篇补肾活血
  • 3篇创伤
  • 3篇创伤性
  • 2篇脂联素

机构

  • 6篇华中科技大学

作者

  • 6篇沈霖
  • 6篇杨艳萍
  • 5篇徐晓娟
  • 5篇帅波
  • 3篇李成刚
  • 3篇吕林
  • 2篇伍满香
  • 2篇周丕琪
  • 2篇马陈
  • 2篇谢晶
  • 2篇夏雪

传媒

  • 2篇中国中医骨伤...
  • 2篇Chines...
  • 2篇中西医结合研...
  • 1篇中华实验外科...
  • 1篇Journa...
  • 1篇首都食品与医...

年份

  • 1篇2019
  • 1篇2017
  • 3篇2016
  • 1篇2015
  • 1篇2014
  • 1篇2013
  • 1篇2012
9 条 记 录,以下是 1-9
排序方式:
青娥方对绝经后骨质疏松伴有骨痛患者血清IGF-1、IL-6以及TNF-α水平的影响被引量:15
2014年
目的:观察古方青娥丸治疗绝经后骨质疏松症患者腰背疼痛的近期疗效,以及对患者血清中IGF-1、IL-6以及TNF-α水平的影响。方法:60例绝经后骨质疏松患者随机分为,青娥丸治疗组(治疗组)和对照组。治疗组每次口服青娥丸1丸,每日3次,同时口服钙尔奇D 600mg,每日1次。对照组每日口服钙尔奇D 600mg,两组均治疗3个月。重点观察患者腰背疼痛疗效;并于治疗前后取空腹血清,Elisa法检测血清中IGF-1、IL-6以及TNF-α的水平。结果:治疗组疼痛症状明显好转,且明显优于对组组(P<0.05);血清中IL-6以及TNF-α的水平明显降低,IGF-1水平升高,对照组不显,组间疗后比较差异有统计学意义(P<0.001)。结论:青娥方治疗绝经后骨质疏松所致的腰背疼痛效果显著,且安全,其机制可能与降低体内IL-6、TNF-α水平,增加IGF-1水平,抑制绝经后代谢性骨丢失,促进骨形成有关。
刘景科沈霖杨艳萍徐晓娟
关键词:绝经后骨质疏松青娥丸胰岛素样生长因子-1
非创伤性股骨头坏死患者ADAM17介导的凝血酶受体水解活性研究及加味青娥丸对其的干预效应被引量:1
2016年
目的观察加味青娥丸对非创伤性股骨头坏死(ONFH)患者解离素金属酶17(ADAM17)介导的凝血酶受体水解活性的影响,探讨加味青娥丸治疗缺血性ONFH的机制。方法招募临床诊断为非创伤性ONFH患者60例,随机分为治疗组及对照组,治疗组给予加味青娥丸及补钙治疗,对照组给予模拟剂及补钙治疗,2组疗程均为6个月,2组患者适当限制运动及负重,另招募60例健康体检者作为健康组。抽取2组患者治疗前后及健康组静脉血,采用ELISA法检测受试者血浆中ADAM17表达水平;流式细胞仪检测受试者凝血酶受体GPⅠb/Ⅸ/Ⅴ和GPⅠbα的表达,同步观察患者治疗前后髋关节功能评分(Harris评分)及髋部X摄片影像学变化,比较3组上述指标的差异。结果非创伤性ONFH患者ADAM17表达水平明显低于健康组;GPⅠb/Ⅸ/Ⅴ和GPⅠbα高于健康组。治疗6月后,治疗组ADAM17显著高于对照组,GPⅠb/Ⅸ/Ⅴ和GPⅠbα表达水平显著低于对照组;治疗组髋关节Harris评分优于对照组;2组髋部X摄片影像学无明显差异。结论中药加味青娥丸方提高非创伤性ONFH患者低于正常的ADAM17含量,调节其介导的凝血酶受体水解活性,可能是本方治疗非创伤性ONFH患者的疗效机制之一。
沈霖马陈帅波杨艳萍徐晓娟夏雪吕林
关键词:股骨头坏死青娥丸凝血酶受体
非创伤性股骨头坏死患者癌胚抗原相关细胞黏附分子1及脂联素信号转导通路相关分子表达的相关性
2016年
目的 检测非创伤性股骨头坏死(ONFH)患者癌胚抗原相关细胞黏附分子1(CEACAM1)的表达,探讨其与脂联素、脂联素受体1(AdipoR1)和脂联素受体2(AdipoR2)、一氧化氮(NO)、内皮型一氧化氮合酶(eNOS)表达的相关性.方法 采用酶联免疫吸附试验(ELISA)方法分别检测ONFH患者(ONFH组)和健康对照组(n=60)的血清CEACAM1、脂联素、NO水平,采用反转录-聚合酶链反应(RT-PCR)的方法检测两组的血浆CEACAM1、脂联素、AdipoR1、AdipoR2、eNOS的表达.结果 ONFH组患者的血清CEACAM1、脂联素、NO的水平与健康对照组比较差异有统计学意义[(5.35±2.21) ng/ml比(21.57±5.38) ng/ml;(4.26±1.05) μg/ml比(12.21±4.89) μg/ml;(10.31±2.15) μmol/L比(35.13±5.07) μmol/L,P<0.05],两组CEACAM1、脂联素、AdipoR1、AdipoR2及eNOS mRNA表达比较差异有统计学意义(4.03±1.31比7.35±1.05;10.26±2.57比20.13±3.54;11.23±1.52比19.28±2.37;10.19±1.18比21.72±2.19;15.19±2.01比31.12±3.18,P<0.05);CEACAM1的表达与ONFH呈负相关(r=-0.236,P<0.01).ONFH组患者血清CEACAM1的水平与脂联素及NO的水平呈正相关(r=O.179、0.237,P<0.01),CEACAM1 mRNA表达与脂联素及其受体、eNOS mRNA表达呈正相关(r=0.157、0.372、0.253、0.154,P<0.01).结论 非创伤性ONFH患者的CEACAM1的表达与脂联素信号转导通路相关分子的表达关系密切.
马陈沈霖杨艳萍帅波徐晓娟李成刚吕林夏雪
关键词:癌胚抗原相关细胞黏附分子1脂联素一氧化氮非创伤性股骨头坏死
补肾活血方治疗早期缺血性股骨头坏死患者的临床研究被引量:22
2013年
目的:探讨补肾活血方对早期缺血性股骨头坏死患者骨髓水肿、疼痛VAS评分、Harris评分及体内脂联素、CRP、TNF-α和NO等相关因子水平的影响。方法:将我院门诊及住院部2010年5月-2010年10月收治的120例缺血性股骨头坏死患者(138髋)随机给予基础+加味青娥丸治疗(治疗组,n=71)及基础+钙片(对照组,n=49)治疗,随访24周,分析治疗前后两组患者骨髓水肿、疼痛VAS评分、Harris评分及体内脂联素、CRP、TNF-α和NO等相关因子水平的变化。结果:治疗前治疗组与对照组分别有62髋和43髋发生骨髓水肿,发生率分别为75.61%和76.79%(P>0.05)。治疗24周后治疗组17髋骨髓水肿消退,34髋改善,8髋无明显变化,2髋加重,对照组3髋骨髓水肿消退,11髋改善,23髋无明显变化,6髋加重,两组治疗有效率(消退+改善率)分别为82.26%和32.56%(P<0.05)。在治疗组中,治疗后VAS评分明显低于治疗前(P<0.01),而Harris评分则明显高于治疗前(P<0.01)。在对照组中VAS评分及Harris评分在治疗前后比较差异无统计学意义(P>0.05)。在治疗组中,治疗后血清脂联素水平高于治疗前(P<0.01),而CRP、TNF-α及NO含量则低于治疗前(P<0.05)。在对照组中血清脂联素、CRP、TNF-α及NO含量在治疗前后比较差异无统计学意义(P>0.05)。结论:加味青娥丸可有效的改善早期缺血性股骨头坏死患者脂联素等相关因子水平,缓解骨髓水肿及临床症状,提高患者生命质量,值得临床推广。
帅波沈霖杨艳萍谢晶周丕琪徐晓娟李成刚伍满香
关键词:骨髓水肿股骨头缺血性坏死脂联素青娥丸
青娥丸加味治疗非创伤性股骨头缺血性坏死的有效性与安全性的前瞻性临床研究被引量:1
2016年
目的观察青娥丸加味治疗非创伤性股骨头缺血性坏死的有效性与安全性,为缺血性股骨头坏死提供一种可行且有效的治疗方法。方法本试验采用随机方式分为实验组与对照组,试验组试验药为青娥丸加味,对照药为钙剂(钙尔奇D 600mg qd)。将纳入试验的40例患者随机分为试验组与对照组,以影像学检查疗效、Harris评分作为疗效评价指标,以血常规、肝功能、肾功能、凝血功能作为安全性评价指标。治疗进行24周,分析统计随访结果。结果治疗组影像学CT有效率为73.33%,对照组为42.30%(t﹤0.05)。治疗组Harris评分为70.75高于对照组57.43。治疗过程中安全指标未出现明显异常。结论对于非创伤性股骨头坏死患者,青娥丸加味是明显有效和安全的。
吕林沈霖杨艳萍帅波
关键词:非创伤性股骨头缺血性坏死补肾活血
Effects of Modified Qing'e Pill(加味青娥丸) on Expression of Adiponectin,Bone Morphogenetic Protein 2 and Coagulation-Related Factors in Patients with Nontraumatic Osteonecrosis of Femoral Head被引量:6
2017年
Objective: To observe the regulation of Chinese herbal medicine, Modified Qing'e Pill(加味青娥丸, MQEP), on the expression of adiponectin, bone morphogenetic protein 2(BMP2), osteoprotegerin(OPG) and other potentially relevant risk factors in patients with nontraumatic osteonecrosis of the femoral head(ONFH). Methods: A total of 96 patients with nontraumatic ONFH were unequal randomly divided into treatment group(60 cases) and control group(36 cases). The treatment group were treated with MQEP while the control group were treated with simulated pills. Both groups were given caltrate D. Six months were taken as a treatment course. Patients were followed up every 2 months. The levels of plasma adiponectin, BMP2, OPG, von Willebrand factor(vWF), von Willebrand factor cleaving protease(vWF-cp), plasminogen activator inhibitor 1(PAI-1), tissue plasminogen activator(tPA), C-reactive protein(CRP), blood rheology, bone mineral density(BMD) of the femoral head and Harris Hip Score were measured before and after treatment. Results: After 6 months of treatment, compared with the control group, patients in the treatment group had significantly higher adiponectin and BMP2 levels(P<0.01 and P=0.013, respectively), lower vWF, PAI-1 and CRP levels(P=0.019, P<0.01 and P<0.01, respectively), and lower blood rheology parameters. BMD of the femoral neck, triangle area and Harris Hip Score in the treatment group were significantly higher than those in the control group. Moreover, plasma adiponectin showed a positive association with BMP2(r=0.231, P=0.003) and a negative association with PAI-1(r=–0.159, P<0.05). Conclusions: MQEP may play a protective role against nontraumatic ONFH by increasing the expression of adiponectin, regulating bone metabolism and improving the hypercoagulation state, which may provide an experimental base for its clinical effects.
LI Cheng-gangSHEN LinYANG Yan-PingXU Xiao-JuanSHUAI BoMA Chen
关键词:骨形态发生蛋白WILLEBRAND因子纤溶酶原激活物抑制物
Association of Serum Dkk-1 Levels with β-catenin in Patients with Postmenopausal Osteoporosis被引量:7
2015年
Wnt signaling plays an important role in the bone development and remodeling. The Wnt antagonist Dkk-1 is a potent inhibitor of bone formation. The aims of this study were firstly to compare the serum Dkk-1 levels in postmenopausal osteoporosis patients with age-matched healthy controls, and secondly, to assess the possible relationship between Dkk-1 and β-catenin, sclerostin, or bone turnover markers [CTX, PINP, N-MID-OT and 25(OH)D] in the setting of postmenopausal osteoporosis. A total of 350 patients with postmenopausal osteoporosis and 150 age-matched healthy controls were enrolled, and the serum levels of Dkk-1, β-catenin, sclerostin, OPG, and RANKL were detected by ELISA, and bone turnover markers [CTX, PINP, N-MID-OT and 25(OH)D] were measured by Roche electrochemiluminescence system in two groups. Serum Dkk-1 levels were significantly higher in postmenopausal osteoporosis group than in control group(P<0.001). Univariate analyses revealed that serum Dkk-1 levels were weakly negatively correlated to β-catenin(r=–0.161, P=0.003) and OPG(r=–0.106, P=0.047), while multiple regression analysis showed a negative correlation between serum Dkk-1 levels with β-catenin(β=–0.165, P=0.009) and BMD(β=–0.139, P=0.027), and a positive correlation between serum Dkk-1 levels and CTX(β=0.122, P=0.040) in postmenopausal osteoporosis group. No similar correlations ware observed in control group. The results provided evidence for the role of Dkk-1 in bone metabolism and demonstrated the link of Dkk-1 and Wnt/β-catenin in some ways.
田峻徐晓娟沈霖杨艳萍朱锐帅波朱习文李成刚马陈吕林
关键词:绝经后ELISA法
Positive Effects of Qing'e Pill(青娥丸)on Trabecular Microarchitecture and its Mechanical Properties in Osteopenic Ovariectomised Mice被引量:4
2019年
Objective: To investigate the impact of Qing'e Pill(青娥丸,QEP) on the cancellous bone microstructure and its effect on the level of β-catenin in a mouse model of postmenopausal osteoporosis.Methods: Ninety-six 8-week-old speci?c pathogen free C57 BL/6 mice were randomly divided into 4 groups(24/group): sham,ovariectomised osteoporosis model,oestradiol-treated,and QEP-treated groups.Three months after surgery,the third lumbar vertebra and left femur of the animals were dissected and scanned using micro-computed tomography(micro-CT) to acquire three-dimensional(3 D) parameters of their cancellous bone microstructure.The impact of ovariectomy,the effect of oestradiol and QEP intervention on cancellous bone microstructure,and the expression of β-catenin were evaluated.Results: The oestradioland the QEP-treated groups exhibited a signi?cant increase in the bone volume fraction,trabecular number,trabecular thickness,bone surface to bone volume ratio(BS/BV),and β-catenin expression compared with those of the model group(P<0.05).In contrast,the structure model index,trabecular separation,and BS/BV were signi?cantly decreased compared with those of the ovariectomised osteoporosis model group(P<0.05).No differences were observed in the above parameters between animals of the QEP-and oestradiol-treated groups.Conclusions: The increased β-catenin expression may be the mechanism underlying QEP's improvement of the cancellous bone microstructure in ovariectomised mice.Our ?ndings provide a scienti?c rationale for using QEP as a dietary supplement to prevent bone loss in postmenopausal women.
SHUAI BoZHU RuiYANG Yan-pingSHEN LinXU Xiao-juanMA ChenLU Lin
关键词:OSTEOPOROSISTOMOGRAPHYOESTRADIOLPILLΒ-CATENIN
补肾活血方对激素性股骨头坏死大鼠BMSCs分化影响的研究被引量:8
2012年
目的探讨补肾活血方含药血清对激素性股骨头坏死大鼠股骨近端骨髓间充质细胞体外分化的影响。方法建立激素性股骨头坏死大鼠模型后,提取股骨近端骨髓单个核细胞,随机分为4组培养,空白血清对照组(A组)、补肾活血方含药血清低(B组)、中(C组)、高(D组)浓度组,分别加入重组人骨形态发生蛋白-2(rhBMP-2)诱导下的骨髓间充质细胞的培养体系,观察各组的细胞形态学、细胞内ALP含量及TGF-β1基因表达。结果补肾活血方含药血清能增强rhBMP-2的活性,促进股骨近端骨髓体外成骨细胞的分化增殖(P<0.01),促进分化中的骨髓间充质细胞表达TGF-β1mRNA(P<0.01)。结论补肾活血方通过增强rhBMP-2活性及TGF-β1mRNA的表达在骨坏死的修复中起关键作用。
帅波沈霖杨艳萍谢晶周丕琪徐晓娟李成刚伍满香
关键词:股骨头缺血性坏死骨髓间充质细胞补肾活血方转化生长因子-Β1
共1页<1>
聚类工具0